Dr. Mingqiu Chen 陈明秋
Chief Physician, Associate Professor
Department of Radiation Oncology, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiotherapy for common tumors, with a focus on head and neck cancers and thoracic and abdominal malignancies.
Dr. Chen holds an MD and serves as Chief Physician and Associate Professor at Fujian Medical University. Training includes a clinical medicine degree from Shanghai Railway Medical College (1997), a master’s in oncology from Fujian Medical University (2003), and a PhD in oncology from Soochow University (2018). Dr. Chen conducted research at the University of Florida and studied proton therapy at Jacksonville Cancer Center (2017–2018). Clinical work focuses on combined chemoradiotherapy for esophageal, lung, thymic, mediastinal, and soft tissue tumors.
Professional roles
- Deputy Secretary-General, Esophageal Cancer Expert Committee, Tumor Rehabilitation Branch, Chinese Association of Gerontology and Geriatrics
- Standing Committee Member, Nasopharyngeal Carcinoma Professional Committee, Fujian Anti-Cancer Association
- Member, Oral Tumor Professional Committee, Fujian Tumor Prevention and Control Alliance
- Editorial Board Member, TMR
Name order: in Chinese the family name comes first (Chen Mingqiu). Papers usually list the name as Mingqiu Chen or Chen M.
Selected publications
24 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Gastrointest Oncol, 2025 (senior author): Survival analysis of small cell carcinoma of the esophagus: a 15-year retrospective study from a high-incidence region. PubMed 41522760
- BMC Cancer, 2023 (senior author): Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy. PubMed 38053017
- Sci Rep, 2023 (senior author): Efficacy and complications of single-port thoracoscopic minimally invasive esophagectomy in esophageal squamous cell carcinoma: a single-center experience. PubMed 37770495
- Ann Transl Med, 2022 (senior author): Multi-omics profiling identifies C1QA/B(+) macrophages with multiple immune checkpoints associated with esophageal squamous cell carcinoma (ESCC) liver metastasis. PubMed 36544679
- Radiat Oncol, 2022 (senior author): Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer. PubMed 35850908
- Front Oncol, 2020 (senior author): Analysis of Factors Affecting Brain Metastasis in Limited-Stage Small-Cell Lung Cancer Treated With Definitive Thoracic Irradiation. PubMed 33194620
- BMC Cancer, 2020 (first author): Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A). PubMed 31941487
- Cancer Manag Res, 2019 (first author): Primary tumor regression patterns in esophageal squamous cell cancer treated with definitive chemoradiotherapy and implications for surveillance schemes. PubMed 31114372
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion